glp-1 alcohol receptor agonists are promising but unproven treatments for and substance use disorders GLP-1 Anti-Obesity Rx and Alcohol
Description
Recent clinical trial results: A number of high-profile clinical trial findings have driven a material change in the perception of how these drugs may be used in the future
Byetta was discontinued in South Africa as of February 2024
Diabetes Alzheimers Dement
PROMOTE HEALTHY WEIGHT MANAGEMENT**
Natural GLP-1 is produced by the body, however, as we discussed earlier, it has a very short lifespan, and patients with T2D and other metabolic disorders can experience reduced secretion of the hormone or reduced sensitivity to it
